Hyperuricemia is a risk factor for the onset of impaired fasting glucose in men with a high plasma glucose level: A community-based study

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Miyake, Teruki ^a   Kumagi, Teru ^a   Furukawa, Shinya ^a   Hirooka, Masashi ^a   Kawasaki, Keitarou ^a,b   Koizumi, Mitsuhito ^a,b   Todo, Yasuhiko ^a   Yamamoto, Shin ^a   Abe, Masanori ^a   Kitai, Kohichiro ^b   Matsuura, Bunzo ^a   Hiasa, Yoichi ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Ehime General Health Care Association   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; GLUCOSE BLOOD LEVEL;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; COHORT ANALYSIS; COMMUNITY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EVALUATION AND FOLLOW UP; FAMILY HISTORY; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERURICEMIA; IMPAIRED GLUCOSE TOLERANCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; ONSET AGE; PATHOPHYSIOLOGY; POPULATION RESEARCH; PREDICTION; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL; VERY ELDERLY; BLOOD; COMPLICATION; DIET RESTRICTION; GLUCOSE INTOLERANCE; MIDDLE AGED; PREDICTIVE VALUE;

ADULT; BLOOD GLUCOSE; FASTING; GLUCOSE INTOLERANCE; HUMANS; HYPERURICEMIA; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; URIC ACID;

EID: 84907224052     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107882     Document Type: Article

References (37)

1. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, et al. (2006) Epidemic obesity and type 2 diabetes in Asia. Lance; 368: 1681e8.
2. Roubenoff R, Klag MJ, Mead LA, Liang KY, Seidler AJ, et al. (1991) Incidence and risk factors for gout in white men. J Am Med Assoc 266: 3004-3007.
3. Baker JF, Krishnan E, Chen L, Schumacher HR (2005) Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med 118: 816-826.
4. Li Y, Xu C, Yu C, Xu L, Miao M (2009) Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J Hepatol 50: 1029-1034.
5. Taniguchi Y, Hayashi T, Tamura K, Endo G, Fujii S (2001) Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: Osaka Health Survey. J Hypertens 19: 1209-1215.
6. Oda E, Kawai R, Sukumaran V, Watanabe K (2011) Uric acid is positively associated with metabolic syndrome but negatively associated with diabetes in Japanese men. Intern Med 48: 1785-1791.
7. Yamada T, Fukatsu M, Suzuki S, Wada T, Joh T (2011) Elevated serum uric acid predicts impaired fasting glucose and type 2 diabetes only among Japanese women undergoing health checkups. Diabetes Metab 37: 252-258.
8. Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, et al. (2003) Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol 18: 523-530.
9. Meisinger C, Döring A, Stöckl D, Thorand B, Kowall B, et al. (2012) Uric acid is more strongly associated with impaired glucose regulation in women than in men from the general population: the KORA F4-Study. PLoS One 7: e37180.
10. Kawamoto R, Tabara Y, Kohara K, Kusunoki T, Abe M, et al. (2013) Serum uric acid is more strongly associated with impaired fasting glucose in women than in men from a community-dwelling population. PLoS One 8: e65886.
11. Kodama S, Saito K, Yachi Y, Asumi M, Sugawara A, et al. (2009) Association between serum uric acid and development of type 2 diabetes. Diabetes Care 32: 1737-1742.
12. Anton FM, Garcia Puig J, Ramos T, Gonzalez P, Ordas J (1986) Sex differences in uric acid metabolism in adults: evidence for a lack of influence of estradiol-17 beta (E2) on the renal handling of urate. Metabolism 35: 343-348.
13. Sumino H, Ichikawa S, Kanda T, Nakamura T, Sakamaki T (1999) Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia. Lancet 354: 650.
14. World Health Organization: Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Geneva: Warld Health Organization, 2006.
15. Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, et al. (2002) Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract 55: 65-85.
16. Yamada T, Fukatsu M, Suzuki S, Wada T, Yoshida T, et al. (2010) Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup. J Gastroenterol Hepatol 25: 352-356.
17. Unwin N, Shaw J, Zimmet P, Alberti KG (2002) Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 19: 708-723.
18. Chen KT, Chen CJ, Gregg EW, Imperatore G, Narayan KM (2003) Impaired fasting glucose and risk of diabetes in Taiwan: follow-up over 3 years. Diabetes Res Clin Pract 60: 177-182.
19. Moebus S, Stang A, Möhlenkamp S, Dragano N, Schmermund A, et al. (2009) Association of impaired fasting glucose and coronary artery calcification as a marker of subclinical atherosclerosis in a population-based cohort-results of Heinz Nixdorf Recall Study. Diabetologia 52: 81-89.
20. Kato M, Noda M, Suga H, Matsumoto M, Kanazawa Y (2009) Fasting plasma glucose and incidence of diabetes-implication for the threshold for impaired fasting glucose: results from the population-based Omiya MA cohort study. J Atheroscler Thromb 16: 857-861.
21. Moriuchi T, Oka R, Yagi K, Miyamoto S, Nomura H, et al. (2010) Diabetes progression from "high-normal" glucose in school teachers. Intern Med 49: 1271-1276.
22. Miyake T, Kumagi T, Hirooka M, Koizumi M, Furukawa S, et al. (2012) Metabolic markers and ALT cutoff level for diagnosing nonalcoholic fatty liver disease: a community-based cross-sectional study. J Gastroenterol 47: 696-703.
23. Miyake T, Kumagi T, Hirooka M, Furukawa S, Koizumi M, et al. (2013) Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal cohort study. J Gastroenterol 48: 413-422.
24. Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S (2003) Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol 38: 954-961.
25. American Diabetes Association. Screening for Diabetes (2003) Diabetes care 24 (Suppl. 1): s21-24.
26. Harita N, Hayashi T, Sato KK, Nakamura Y, Yoneda T, et al. (2009) Lower serum creatinine is a new risk factor of type 2 diabetes: the Kansai healthcare study. Diabetes Care 32: 424-6.
27. Jimba S, Nakagami T, Takahashi M, Wakamatsu T, Hirota Y, et al. (2005) Prevalence of nonalcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med 22: 1141-5.
28. Sairenchi T, Iso H, Nishimura A, Hosoda T, Irie F, et al. (2004) Cigarette smoking and risk of type 2 diabetes mellitus among middle-aged and elderly Japanese men and women. Am J Epidemiol 160: 158-62.
29. Waki K, Noda M, Sasaki S, Matsumura Y, Takahashi Y, et al. (2005) JPHC Study Group. Alcohol consumption and other risk factors for self-reported diabetes among middle-aged Japanese: a population-based prospective study in the JPHC study cohort I. Diabet Med 22: 323-31.
30. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, et al. (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int 67: 1739-1742.
31. Roy D, Perreault M, Marette A (1998) Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. Am J Physiol 274: E692-E699.
32. Sautin YY, Nakagawa T, Zharikov S, Johnson RJ (2007) Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Cell Physiol 293: C584-C596.
33. Schulz E, Gori T, Münzel T (2011) Oxidative stress and endothelial dysfunction in hypertension. Hypertens Res 34: 665-73.
34. Smelcerovic A, Rangelov M, Smelcerovic Z, Veljkovic A, Cherneva E, et al. (2013) Two 6-(propan-2-yl)-4-methyl-morpholine-2, 5-diones as new non-purine xanthine oxidase inhibitors and anti-inflammatory agents. Food Chem Toxicol 55: 493-7.
35. Quinones-Galvan A, Natali A, Baldi S, Frascerra S, Sanna G, et al. (1995) Effect of insulin on uric acid excretion in humans. Am J Physiol 268: E1-E5.
36. Johnson RJ, Perez-Pozo SE, Sautin YY, Manitius J, Sanchez-Lozada LG, et al. (2009) Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocr Rev 30: 96-116.
37. Choi HK, Liu S, Curhan G (2005) Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 52: 283-9.